Merus NV Form 4 insider transactions

Harry Shuman, VP Controller, PAO of Merus N.V., reports exercising stock options and selling shares on March 21, 2025.

Harry Shuman, VP Controller, PAO of Merus N.V., reports the vesting of restricted stock units and subsequent conversion to common shares on January 1, 2025.

Merus N.V. CEO Sven Ante Lundberg reported transferring 40,601 common shares to a family trust on February 19, 2025.

Merus N.V. CEO Sven Ante Lundberg exercised stock options and acquired common shares on February 13, 2025.

Harry Shuman, VP Controller and PAO of Merus N.V., was granted stock options for 23,420 common shares on January 29, 2025, vesting over four years.

Merus N.V. Chief Operating Officer and General Counsel, Peter Silverman, was granted 125,000 stock options on January 29, 2025.

Merus N.V.'s CEO, Sven Ante Lundberg, was granted 300,000 share options with a strike price of $41.65, vesting over four years.

Merus N.V.'s Chief Financial Officer, Gregory D. Perry, was granted 100,000 share options on January 29, 2025, which vest over a four-year period.

Fabian Zohren, Chief Medical Officer of Merus N.V., reports the acquisition of 50,000 share options with an exercise price of $41.65.

Harry Shuman, VP Controller, PAO of Merus N.V., exercised stock options and sold shares of common stock on August 20 and 21, 2024.

Fabian Zohren, Chief Medical Officer of Merus N.V., reports the acquisition of share options exercisable for 183,943 ordinary shares, vesting over four years commencing July 1, 2024.

Peter Silverman, COO & GC of Merus N.V., executed option exercises and subsequent sales of common shares under a pre-arranged 10b5-1 trading plan on June 27, 2024.

Peter Silverman, COO & GC of Merus N.V., exercised stock options and sold shares on June 17, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Harry Shuman, VP Controller, PAO of Merus N.V., reports exercising stock options and selling shares, resulting in adjusted beneficial ownership.

Harry Shuman, VP Controller, PAO of Merus N.V., reports the acquisition and disposal of common shares and the exercise of share options on June 4, 2024.

Director Jason Haddock acquired 17,688 share options in Merus N.V. on May 7, 2024, vesting over three years.

Director Paolo Pucci acquired 8,844 share options in Merus N.V. on May 7, 2024, vesting over one year.

Harry Shuman, VP Controller, PAO of Merus N.V., reports the acquisition of stock options after shareholder approval of an amendment to the company's articles of association.

Merus N.V.'s CEO, Sven Ante Lundberg, received options to purchase 360,000 common shares after the company's shareholders approved an amendment to increase authorized share capital.

Hui Liu, EVP, CBO & Head of Merus US, was granted options to purchase 107,300 common shares of Merus N.V. following shareholder approval of an increase in authorized share capital.

Andrew Joe, SVP, CMO of Merus N.V., reports the acquisition of stock options following shareholder approval of an increase in authorized share capital.

Director Victor Sandor acquired 8,844 share options in Merus N.V. at an exercise price of $48.73 on May 7, 2024.

Gregory D. Perry, CFO of Merus N.V., was granted options to purchase 107,300 common shares after the company's shareholders approved an increase in authorized share capital.

Director Len Kanavy acquired share options in Merus N.V. on May 7, 2024.

Director Anand Mehra acquired 8,844 share options in Merus N.V. on May 7, 2024, vesting over one year.

Director Mark T Iwicki acquired 8,844 share options in Merus N.V. on May 7, 2024, vesting monthly over one year.

Peter Silverman, COO & GC of Merus N.V., reports the acquisition of 107,300 share options after the company's shareholders approved an amendment to increase authorized share capital.

Director Maxine Gowen acquired 8,844 share options in Merus N.V. on May 7, 2024, vesting monthly over one year.